Patents by Inventor Barry Aldous

Barry Aldous has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND DOSAGE FORMS FOR TREATMENT OF HPV INFECTION AND HPV-INDUCED NEOPLASIA
    Publication number: 20240150381
    Abstract: A pharmaceutically acceptable salt of an acyclic nucleotide phosphoramidate to treat HPV and related conditions including neoplasia, as well as pharmaceutical compositions, morphic forms and dosage forms thereof.
    Type: Application
    Filed: October 31, 2023
    Publication date: May 9, 2024
    Applicant: Antiva Biosciences, Inc.
    Inventors: Barry Aldous, Ramakrishna Gadiraju, Sarah Walter, Oranee Daniels, Gail Maderis, Ankush Argade, Ravichandran Mahalingam, Zhengle Zhao, Zhaoyang Qin, Siyi Jiang, Runyan Li
  • TREATMENT OF HPV-INDUCED NEOPLASIA
    Publication number: 20240139221
    Abstract: A pharmaceutically acceptable salt of an acyclic nucleotide phosphoramidate to treat HPV and related conditions including neoplasia, as well as pharmaceutical compositions, morphic forms and dosage forms thereof.
    Type: Application
    Filed: October 31, 2023
    Publication date: May 2, 2024
    Applicant: Antiva Biosciences, Inc
    Inventors: Barry Aldous, Ramakrishna Gadiraju, Sarah Walter, Oranee Daniels, Gail Maderis, Ankush Argade, Ravichandran Mahalingam, Zhengle Zhao, Zhaoyang Qin, Siyi Jiang, Runyan Li
  • TREATMENT OF HPV INFECTION
    Publication number: 20240139220
    Abstract: A pharmaceutically acceptable salt of an acyclic nucleotide phosphoramidate to treat HPV and related conditions including neoplasia, as well as pharmaceutical compositions, morphic forms and dosage forms thereof.
    Type: Application
    Filed: October 31, 2023
    Publication date: May 2, 2024
    Applicant: Antiva Biosciences, Inc.
    Inventors: Barry Aldous, Ramakrishna Gadiraju, Sarah Walter, Oranee Daniels, Gail Maderis, Ankush Argade, Ravichandran Mahalingam, Zhengle Zhao, Zhaoyang Qin, Siyi Jiang, Runyan Li
  • Stable compositions
    Patent number: 6071428
    Abstract: In a composition which has an amorphous, undercooled, glassy phase containing a water-soluble or water-swellable substance in an amorphous form, a sugar, which is capable of existing as a crystalline hydrate, is used as an agent to dehydrate the amorphous phase by crystallization therefrom, and thereby enhance the glass transition temperature of the residual amorphous phase.
    Type: Grant
    Filed: April 26, 1996
    Date of Patent: June 6, 2000
    Assignee: Inhale Therapeutic Systems
    Inventors: Felix Franks, Barry Aldous, Anthony Auffret